Investigating the Efficacy of ApplTree on Prospective Memory in Stroke
Launched by NHS GREATER GLASGOW AND CLYDE · Dec 16, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Background: Prospective memory impairment is common following stroke and can significantly impact daily functioning and quality of life. Studies show that technological memory aids, including smartphone applications, are effective in helping compensate for PM difficulties. Wilson (2021) investigated the efficacy of ApplTree, a smartphone reminder application, in three community-dwelling stroke participants with PM difficulties using a multiple baseline across participants, single case experimental design (SCED). Results indicated that ApplTree did not lead to statistically significant impro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community-dwelling individuals who have had a medically-confirmed stroke that occurred at least 3 months prior to recruitment
- • Participants must have self- or other-reported prospective memory difficulties
- • Participants must share accommodation with their nominated person
- • Participants must own and be competent in the use of a smartphone with a reliable internet connection. Nominated persons must also own and be competent in the use of a smartphone and this phone must be separate to that owned by the participants.
- • Participants must have capacity to provide informed consent
- • Participants must be aged 18 years or over
- Exclusion Criteria:
- • Index stroke \<3 months prior to recruitment
- • Individuals who do not have capacity to provide informed consent
- • Non-fluent English speakers
- • Aged \<18yrs
- • Aphasia (a comprehension and communication disorder that may result from a stroke) that is of a level of severity where it would impact on participants' ability to interact with the ApplTree app and/or complete the study measures
- • Diagnosed pre-existing neurological condition
- • Psychiatric symptoms (e.g., depression) of sufficient severity to prevent engagement with the study
- • Pre-existing dementia or acquired brain injury
- • Cognitive impairment of sufficient severity that it would prevent the participant from using ApplTree
- • Do not currently use a smartphone
- • Physical, visual or auditory impairment which, if uncorrected, would prevent the participant from using a smartphone
- • Currently participating in other research
- • Currently receiving a neuropsychological rehabilitation intervention specifically targeting PM performance
Trial Officials
Jonathan J Evans, BSc, PsyD, PhD
Study Director
University of Glasgow
About Nhs Greater Glasgow And Clyde
NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials